1.07
0.03 (3.02%)
| Previous Close | 1.04 |
| Open | 1.08 |
| Volume | 44,677 |
| Avg. Volume (3M) | 200,822 |
| Market Cap | 2,339,605 |
| Price / Sales | 0.110 |
| Price / Book | 0.390 |
| 52 Weeks Range | |
| Earnings Date | 24 Oct 2024 - 28 Oct 2024 |
| Profit Margin | -256.25% |
| Operating Margin (TTM) | -222.36% |
| Diluted EPS (TTM) | -8.76 |
| Quarterly Revenue Growth (YOY) | -9.20% |
| Total Debt/Equity (MRQ) | 144.39% |
| Current Ratio (MRQ) | 1.21 |
| Operating Cash Flow (TTM) | -14.55 M |
| Levered Free Cash Flow (TTM) | -6.28 M |
| Return on Assets (TTM) | -69.57% |
| Return on Equity (TTM) | -1,476.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | Avinger, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.93 |
|
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 7.94% |
| % Held by Institutions | 10.16% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |